Skip to main content
. 2018 Aug 14;32:2058738418781634. doi: 10.1177/2058738418781634

Figure 5.

Figure 5.

IL-21R expression was associated with OS and tumor recurrence of GC patients. (a) TCGA cohort analysis of the differentially expressed levels of IL-21R in pair-matched tumor tissues as well as in total GC samples. P < 0.001. (b) The cutoff value, sensitivity and specificity of IL-21R was assessed in GC samples (n = 260). (c, d) Kaplan–Meier analysis of the correlation of IL-21R high or low expression with the OS and tumor recurrence of the patients with GC. P < 0.01. Kaplan–Meier analysis of the correlation of IL-21R high or low expression with the OS and tumor recurrence of GC patients (e, f) in early stage (stage I + II; P < 0.01) and (g, h) late stage (stage III + IV; P > 0.05).